For decades, a comfortable story circulated through medical offices, dinner tables, and lifestyle magazines. A glass of red wine with dinner was not merely acceptable — it was, according to the prevailing wisdom, actively good for your heart. The French Paradox. The Mediterranean diet. The observational studies of the 1990s that appeared to show moderate drinkers living longer than abstainers. These findings entered the cultural bloodstream and stayed there.
The science has moved on. The story, largely, has not.
In 2023, the World Health Organization issued a statement that should have made front pages around the world. It did not get the attention it deserved. The statement was unambiguous: when it comes to alcohol consumption, there is no safe amount that does not affect health.
This is not a fringe position. It is the current consensus of the world’s leading cancer and public health bodies — arrived at after decades of accumulating evidence and a fundamental rethinking of how we evaluate the evidence we already had.
What the Evidence Actually Shows
The International Agency for Research on Cancer classified alcohol as a Group 1 carcinogen in 1988 — meaning the evidence that it causes cancer in humans is sufficient and beyond reasonable scientific dispute. The cancers linked to alcohol consumption include cancers of the mouth, pharynx, larynx, oesophagus, liver, colorectal tract, and breast. Seven cancer sites. All dose-dependent. All biologically plausible.
Breast cancer deserves particular attention. The relationship between alcohol and breast cancer risk is dose-dependent, begins at low levels of consumption, and is not modified by the type of alcohol consumed. Even one drink per day increases breast cancer risk by approximately 7–10% relative to lifetime abstinence. For women already at elevated risk, this is a clinically material number.
Alcohol causes cancer through several mechanisms: it metabolises to acetaldehyde, a direct DNA-damaging compound; it generates reactive oxygen species that cause oxidative stress in tissues; it impairs the body’s capacity for DNA repair; it elevates circulating oestrogen. These mechanisms operate regardless of the source of the alcohol. Ethanol is ethanol. The resveratrol in red wine does not neutralise the acetaldehyde.
The Red Wine Myth: What Went Wrong
The cardioprotective reputation of red wine rests primarily on observational research produced in the 1990s and early 2000s. Subsequent scrutiny has substantially undermined these findings through two major methodological problems.
The Sick Quitter Problem. Many early studies comparing drinkers to non-drinkers included in the non-drinking category people who had stopped drinking due to illness — former heavy drinkers, people managing health conditions, individuals who were already unwell. When former drinkers are misclassified as lifetime abstainers, the abstainer group artificially appears less healthy. The moderate drinkers look better by comparison — not because alcohol was protecting them, but because the comparison group was sick.
Confounding Lifestyle Factors. Moderate wine drinkers in the observational studies were, on average, wealthier, better educated, more physically active, ate more vegetables, had better access to healthcare, and smoked less than both abstainers and heavy drinkers. The apparent health benefit was not wine. It was wealth and lifestyle.
More recent Mendelian randomisation studies — which use genetic variants as proxies for alcohol exposure, sidestepping many observational confounds — have consistently failed to confirm any cardiovascular benefit from moderate alcohol consumption.
The Guidelines Are Changing
In January 2023, Canada dramatically revised its national alcohol guidance. The previous guidelines recommended no more than 10 drinks per week for women and 15 for men. The new guidance classifies three or more drinks per week as “moderate risk” for developing cancer or other serious health consequences — and states explicitly that there is no safe amount when it comes to cancer risk.
Australia similarly revised its guidelines in 2020, recommending no more than 10 standard drinks per week and explicitly stating that less is better, with no consumption being safest.
The WHO’s 2023 statement went further still. These are not radical positions from fringe sources. They represent the current position of the world’s most authoritative public health bodies. And yet in clinical settings, in social conversations, and in media coverage, the old narrative persists.
Why the Message Has Not Reached Us
The persistence of the cardioprotection narrative is not accidental. The alcohol industry has invested heavily in funding research, cultivating relationships with academic institutions, and shaping the framing of public debate. A 2020 analysis in the Journal of Studies on Alcohol and Drugs found that industry-funded research was significantly more likely to report favourable outcomes than independently funded studies — and significantly more likely to be cited in guidelines and media coverage.
Healthcare providers, for their part, often received their foundational training during the period when the cardioprotective narrative was ascendant. Updating clinical knowledge requires deliberate effort. That effort is not always made.
What Honest Guidance Looks Like
The science has arrived at a place of uncomfortable clarity. Alcohol is a carcinogen. There is no dose at which its consumption is without risk. The type of alcohol does not meaningfully change that equation.
That does not mean the conversation must be absolutist or shaming. People make complex choices in complex lives. What it does mean is that healthcare providers owe patients an honest account of what the current evidence shows — and that account no longer includes a safe level.
This article is for educational purposes only and does not constitute medical advice. Please consult a qualified healthcare provider regarding your individual health circumstances. CI Mavericks • Together We Heal.